Josep Castellví
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 6
- Virology top 5%
- HIV Research and Treatment 6
- Oncology top 2%
- Cancer Cells and Metastasis 8
- Molecular Biology top 5%
- PI3K/AKT/mTOR signaling in cancer 6
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 11
-
- Endometrial and Cervical Cancer Treatments 13
-
- Lymphoma Diagnosis and Treatment 11
-
- Thyroid Cancer Diagnosis and Treatment 10
- Co-authors
- Santiago Ramón y CajalMatilde E. LleonartJavier Hernández‐LosaAntonio Gil‐MorenoCleofé RomagosaJosé BaselgaFederico RojoA. Mazo
- Cited by
- Cancer ResearchVirologyOncology
- Journals
- Nature Communications (5 papers)Journal of Clinical Oncology (1 paper)The EMBO Journal (1 paper)
- Partner nations
- SpainPalestinian TerritoryUnited States
In The Last Decade
Josep Castellví
107 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Cancer Research 838
- Virology 188
- Oncology 1.0k
- Molecular Biology 1.7k
- Reproductive Medicine 199
Countries citing papers authored by Josep Castellví
This map shows the geographic impact of Josep Castellví's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josep Castellví with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josep Castellví more than expected).
Fields of papers citing papers by Josep Castellví
This network shows the impact of papers produced by Josep Castellví. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josep Castellví. The network helps show where Josep Castellví may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Josep Castellví, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 3 | |
| 4 | 2020 | 14 | |
| 5 | Clinical implications of intratumor heterogeneity: challenges and opportunitiesbreakdown → | 2020 | 313 |
| 6 | 2019 | 74 | |
| 7 | 2019 | 34 | |
| 8 | 2018 | 34 | |
| 9 | 2017 | 2 | |
| 10 | 2017 | 75 | |
| 11 | 2016 | 36 | |
| 12 | 2014 | 42 | |
| 13 | 2014 | 3 | |
| 14 | 2012 | 24 | |
| 15 | 2009 | 66 | |
| 16 | 2009 | 38 | |
| 17 | 2008 | 13 | |
| 18 | 2007 | 47 | |
| 19 | 2007 | 53 | |
| 20 | 2003 | 11 |
About Josep Castellví
Josep Castellví is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Virology, having authored 109 papers that have together received 3.6k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (13 papers), Ovarian cancer diagnosis and treatment (11 papers), Lymphoma Diagnosis and Treatment (11 papers), Thyroid Cancer Diagnosis and Treatment (10 papers), Cancer Cells and Metastasis (8 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Cancer Genomics and Diagnostics (6 papers) and HIV Research and Treatment (6 papers). The work is most often cited by research in Cancer Research (838 citations), Virology (188 citations) and Oncology (1.0k citations). Josep Castellví has collaborated with scholars based in Spain, Palestinian Territory and United States. Frequent co-authors include Santiago Ramón y Cajal, Matilde E. Lleonart, Javier Hernández‐Losa, Antonio Gil‐Moreno, Cleofé Romagosa, José Baselga, Federico Rojo, A. Mazo, Laura López-Vicente and S. Simonetti. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.